Literature DB >> 31791560

Adjuvants in clinical regional anesthesia practice: A comprehensive review.

Amit Prabhakar1, Todd Lambert2, Rachel J Kaye3, Scott M Gaignard4, Joseph Ragusa5, Shannon Wheat6, Vanessa Moll7, Elyse M Cornett8, Richard D Urman9, Alan David Kaye10.   

Abstract

Adjuvants are medications that work synergistically with local anesthetics to help enhance the duration and quality of analgesia in regional techniques. Regional anesthesia has become more prevalent as evidence continues to show efficacy, enhancement of patient care, increased patient satisfaction, and improved patient safety. Practitioners in the perioperative setting need to not only be familiar with regional techniques but also the medications used for them. Some examples of adjuvant medications for regional techniques include dexamethasone, alpha 2 agonists such as clonidine and dexmedetomidine, midazolam, buprenorphine, NMDA antagonists, including ketamine and magnesium, neostigmine, sodium bicarbonate, epinephrine, and non-steroidal anti-inflammatory drugs. The aim of the present investigation, therefore, is to provide a comprehensive review of the most commonly used non-opioid adjuvants in clinical practice today. Regional adjuvants can improve patient safety, increase patient satisfaction, and enhance clinical efficacy. Future studies and best practice techniques can facilitate standardization of regional anesthesia adjuvant dosing when providing nerve blocks in clinical practice. Published by Elsevier Ltd.

Entities:  

Keywords:  adjuvant; dexamethasone; ketamine; magnesium; midazolam; multi-modal; neostigmine; non-steroidal anti-inflammatory medications; regional anesthesia; synergy

Mesh:

Substances:

Year:  2019        PMID: 31791560     DOI: 10.1016/j.bpa.2019.06.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  7 in total

1.  Ultrasound-guided genicular nerve block a new treatment in rheumatology for knee osteoarthritis pain.

Authors:  G Zaragoza; S-Y Solorzano-Flores; C Pineda; C Soto-Fajardo
Journal:  Rheumatol Int       Date:  2022-06-17       Impact factor: 3.580

2.  Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery.

Authors:  Fatma A El Sherif; Hala Abdel-Ghaffar; Ahmed Othman; Sahar Mohamed; Mervat Omran; Samia Shouman; Nivin Hassan; Ayat Allam; Sahar Hassan
Journal:  J Pain Res       Date:  2022-01-04       Impact factor: 3.133

3.  Effectiveness of dexamethasone or adrenaline with lignocaine 2% for prolonging inferior alveolar nerve block: a randomized controlled trial.

Authors:  Saroj Prasad Deo; Md Shakeel Ahmad; Abanish Singh
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2022-02-28

Review 4.  The Options for Neuraxial Drug Administration.

Authors:  Henning Hermanns; Elke M E Bos; Mark L van Zuylen; Markus W Hollmann; Markus F Stevens
Journal:  CNS Drugs       Date:  2022-07-15       Impact factor: 6.497

5.  Effect of Perineural Dexamethasone with Ropivacaine in Continuous Serratus Anterior Plane Block for Postoperative Analgesia in Patients Undergoing Video-Assisted Thoracoscopic Surgery.

Authors:  Jia-Qi Chen; Jie-Ru Chen; Sheng Wang; Wei Gao; Hai Gu; Xin-Lu Yang; Ji-Cheng Hu; Xiao-Qing Chai; Di Wang
Journal:  J Pain Res       Date:  2022-08-13       Impact factor: 2.832

6.  Optimal dose of perineural dexmedetomidine to prolong analgesia after brachial plexus blockade: a systematic review and Meta-analysis of 57 randomized clinical trials.

Authors:  Hai Cai; Xing Fan; Pengjiu Feng; Xiaogang Wang; Yubo Xie
Journal:  BMC Anesthesiol       Date:  2021-09-28       Impact factor: 2.217

7.  Dexmedetomidine-induced hemodynamic instability in patients undergoing orthopedic upper limb surgery under brachial plexus block: a retrospective study.

Authors:  A Ram Doo; Hyungseok Lee; Seon Ju Baek; Jeongwoo Lee
Journal:  BMC Anesthesiol       Date:  2021-09-16       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.